Cervical cancer marker detects high-risk cases
This article was originally published in Clinica
Executive Summary
Matritech's NMP179 protein marker test for cervical cancer detected 92% of high-risk cases that had been identified as equivocal using traditional Pap tests, according to follow-up data from 259 women.